Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,443
Closed -$316K 301
2025
Q4
$316K Buy
+10,443
New +$256K 0.04% 254
2025
Q3
Sell
-221,187
Closed -$5.51M 266
2025
Q2
$5.51M Sell
221,187
-23,344
-10% -$526K 0.82% 30
2025
Q1
$5.73M Buy
244,531
+118,706
+94% +$3.44M 0.88% 22
2024
Q4
$3.52M Sell
125,825
-11,673
-8% -$313K 0.49% 89
2024
Q3
$2.8M Sell
137,498
-14,557
-10% -$326K 0.39% 117
2024
Q2
$4.49M Sell
152,055
-12,496
-8% -$359K 0.65% 55
2024
Q1
$5.02M Buy
164,551
+842
+0.5% +$23.8K 0.7% 42
2023
Q4
$3.83M Sell
163,709
-13,019
-7% -$315K 0.59% 60
2023
Q3
$5.23M Sell
176,728
-6,603
-4% -$221K 0.89% 29
2023
Q2
$6.47M Buy
183,331
+570
+0.3% +$15.9K 1.07% 23
2023
Q1
$4.4M Sell
182,761
-14,713
-7% -$341K 0.78% 37
2022
Q4
$4.39M Sell
197,474
-15,779
-7% -$366K 0.84% 37
2022
Q3
$5.07M Sell
213,253
-30,123
-12% -$812K 0.96% 26
2022
Q2
$5.66M Buy
+243,376
New +$6.55M 1.01% 19

Other funds holding CFLT

Stanley-Laman Group's CFLT Position: Q1 2026 in Review

Stanley-Laman Group sold out of Confluent (CFLT) in Q1 2026, closing a stake of 10,443 shares — an estimated $316K sold.

Stanley-Laman Group first reported a position in CFLT in Q2 2022 and held it in 14 quarters. The position peaked at $6.47M in Q2 2023. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Stanley-Laman Group reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Stanley-Laman Group sold 10,443 Confluent shares in Q1 2026, an estimated $316K.
  • Stanley-Laman Group first reported a position in Confluent in Q2 2022 and held it in 14 quarters.
  • Stanley-Laman Group's Confluent position peaked at $6.47M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Stanley-Laman Group's 13F filing for Q1 2026, filed 16 Apr 2026.